Myeloproliferative Neoplasms (MPN)

11th AAMDSIF and Fred Hutch Cancer Center Conference on Aplastic Anemia, MDS/AML, MPN and PNH 9:05 AM PT - 4:15 PM PT

Thumbnail for video Register Now

Topic(s)
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Bone Marrow Transplant
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
11th AAMDSIF and Fred Hutch Cancer Center Conference on Aplastic Anemia, MDS/AML, MPN and PNH 9:05 AM PT - 4:15 PM PT AAMDSIF and Fred Hutch Cancer Center are pleased to present the 11th Patient Conference, focusing on Aplastic Anemia, MDS, MPN, and PNH. After the presentations…

Reshma Ramlal, MD

Institution
Moffitt Cancer Center
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
About

Dr. Reshma Ramlal is a hematologist-oncologist at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. She specializes in bone marrow transplantation and cellular immunotherapy, with a clinical and research focus on allogeneic transplantation for myeloid malignancies, including acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. She is particularly recognized for advancing safe and effective transplantation in the elderly population, offering individualized treatment plans that emphasize both survival and quality of life. In her clinical

Health-Related Quality of Life, AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium

Thumbnail for video Watch Now

Presenter(s)
Namrata Chandhok, MD
Thomas LeBlanc, MD, MA
Fabio Efficace, PhD
Alison R. Kavanaugh
Pamela C. Egan, MD
Wil L. Santivasi, MD
The session was recorded at the AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium, Co-Chairs Namrata Chandhok, MD, and Thomas LeBlanc, MD, MA Topics and speakers included: How can we measure quality of life in MDS, to inform interventions? - Fabio Efficace, PhD…

Non-Transplant Therapies for Marrow Failure, AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium

Thumbnail for video Watch Now

Presenter(s)
Carlos DeCastro, MD
Phil Scheinberg, MD
Regis Peffault de Latour, MD, PhD
Julian Sevilla, MD, PhD
Kasiani Myers, MD
Suneet Agarwal, MD, PhD
This session was presented at the AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium; Co-Chairs Carlos DeCastro, MD, and Phil Scheinberg, MD, PhD. Session topics included: -Androgens, alemtuzumab, anti-cytokine therapies (anti-IL2R, anti-IFN gamma), daratumumab…

Matteo Della Porta, MD

Institution
Humanitas Cancer Center
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
About

Matteo Giovanni Della Porta is head of Leukemia Unit at Humanitas Cancer Center in Milan, where he is also the head of the Genomics of Hematological Neoplasms Lab. He is full professor of Hematology at Humanitas University and director of the Center for Acclelerating Leukemia/Lymphoma Research, a joint effort from Humanitas University, Humanitas Research Hospital, Humanitas AI Center and the Politecnico di Milano. He obtained his Medical Degree with honors at the University of Pavia Medical School, Italy in 1999. From 2000 to 2003 he completed his training in Hematology at the Department of

Subscribe to Myeloproliferative Neoplasms (MPN)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.